The first time I argued preemption in a case against a generic drug manufacturer was well over a decade ago (had a pretty good result too - the plaintiff dismissed the lawsuit and never refiled it - gotta love that). Back then, preemption wasn't getting the attention it is getting today. Over the years, I've argued preemption in a number of pharmaceutical cases and in doing so have explored a great deal of the history of the federal Food, Drug, and Cosmetic Act. It actually is quite interesting, although I'm sure there are any number of people who would say I have a sick sense of what is interesting.
However, other issues I find interesting and plan to discuss include fraudulent joinder and removal, due process for defendants, and application of the statute of limitations and the discovery rule. In some of areas, I think the law has morphed over the years as courts have addressed them.
I'm not sure how often I will post. Much depends on available time. But, that said, let's begin . . . .
No comments:
Post a Comment